UPDATE: BioMimetic Therapeutics (BMTI) Sees Upside on Stronger Volume
Tweet
Share
E-mailGet Alerts BMTI Hot Sheet
Join SI Premium – FREE
(Updated - June 22, 2012 11:12 AM EDT)
BioMimetic Therapeutics (Nasdaq: BMTI) vlatility is up 8.6 percet as shares run 15 percent higher early on the day.
Shares are getting above their 200-day DMA of $2.67.
This is the highest shares have been since last October.
UPDATE - Shares are moving following positive news Thursday that its Augment Injectable Bone Graft (AIBG) met its primary endpoint of non-inferiority of AIBG to autograft as assessed by CT scan at six months.
For more color, click here.
BioMimetic Therapeutics (Nasdaq: BMTI) vlatility is up 8.6 percet as shares run 15 percent higher early on the day.
Shares are getting above their 200-day DMA of $2.67.
This is the highest shares have been since last October.
UPDATE - Shares are moving following positive news Thursday that its Augment Injectable Bone Graft (AIBG) met its primary endpoint of non-inferiority of AIBG to autograft as assessed by CT scan at six months.
For more color, click here.
Create E-mail Alert Related Categories
Insiders' Blog, Momentum MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
